Surgery remains the best solution for patients with soft‐tissue sarcomas

Abstract

Study co-author Hans-Georg Kopp, MD, from the department of medical oncology, hematology, immunology, rheumatology, and pulmonology at the University of Tubingen in Germany, says that to the authors’ knowledge, only a small number of retrospective studies have reported a survival benefit for patients with soft-tissue sarcoma after complete resection of pulmonary metastases. “While our study does not break new ground, it does confirm what others have found previously: surgical removal of metastases may be beneficial in sarcoma patients, especially if they have been carefully selected. Indeed, clinical characteristics such as resectability of metastases, time of recurrence, and number of metastases are helpful biomarkers when it comes to the consideration of metastasectomy in individual cases.”